Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, et al. Multistate point-prevalence survey of health care–associated infections. N Engl J Med. 2014;370(13):1198–208.
Article
CAS
PubMed
Google Scholar
Antibiotic resistance theats in the United States. Centers for Disease Control and Prevention; 2013, http://www.cdc.gov/drugresistance/threat-report-2013.
Lucado J, Gould C, Elixhauser A. Clostridium difficile infections (CDI) in hospital stays, 2009: statistical brief #124. 2012.
Google Scholar
Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, et al. Burden of Clostridium difficile infection in the united states. N Engl J Med. 2015;372(9):825–34.
Article
CAS
PubMed
Google Scholar
Lipp MJ, Nero DC, Callahan MA. Impact of hospital-acquired Clostridium difficile. J Gastroenterol Hepatol. 2012;27(11):1733–7.
Article
PubMed
Google Scholar
Kyne L, Hamel MB, Polavaram R, Kelly CP. Health care costs and mortality associated with nosocomial diarrhea Due to Clostridium difficile. Clin Infect Dis. 2002;34(3):346–53.
Article
PubMed
Google Scholar
Elixhauser A, Steiner C, Gould C. Readmissions following Hospitalizations with Clostridium difficile Infections, 2009: Statistical Brief #145. Rockville MD: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs; 2006.
Google Scholar
Dubberke ER, Olsen MA. Burden of Clostridium difficile on the healthcare system. Clin Infect Dis. 2012;55 suppl 2:S88–92.
Article
PubMed Central
PubMed
Google Scholar
Kelly CP. Can we identify patients at high risk of recurrent Clostridium difficile infection? Clin Microbiol Infect. 2012;18:21–7.
Article
PubMed
Google Scholar
Khanna S, Pardi DS. The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings. Expert Rev Gastroenterol Hepatol. 2010;4(4):409–16.
Article
PubMed
Google Scholar
Bakken JS. Fecal bacteriotherapy for recurrent Clostridium difficile infection. Anal Chem. 2009;15(6):285–9.
Google Scholar
Pépin J, Alary M-E, Valiquette L, Raiche E, Ruel J, Fulop K, et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis. 2005;40(11):1591–7.
Article
PubMed
Google Scholar
Figueroa I, Johnson S, Sambol SP, Goldstein EJC, Citron DM, Gerding DN. Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin. Clin Infect Dis. 2012;55 suppl 2:S104–9.
Article
CAS
PubMed Central
PubMed
Google Scholar
Surawicz CM. Treatment of recurrent Clostridium difficile-associated disease. Nat Clin Pract Gastroenterol Hepatol. 2004;1(1):32–8.
Article
PubMed
Google Scholar
Petrella LA, Sambol SP, Cheknis A, Nagaro K, Kean Y, Sears PS, et al. Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. Difficile BI strain. Clin Infect Dis. 2012;55(3):351–7.
Article
CAS
PubMed Central
PubMed
Google Scholar
Blaser M, Bork P, Fraser C, Knight R, Wang J. The microbiome explored: recent insights and future challenges. Nat Rev Microbiol. 2013;11(3):213–7.
Article
CAS
PubMed
Google Scholar
Buffie CG, Pamer EG. Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol. 2013;13(11):790–801.
Article
CAS
PubMed Central
PubMed
Google Scholar
Tosh PK, McDonald LC. Infection control in the multidrug-resistant era: tending the human microbiome. Clin Infect Dis. 2011;54(5):707–13.
Article
PubMed
Google Scholar
Abt MC, Pamer EG. Commensal bacteria mediated defenses against pathogens. Curr Opin Immunol. 2014;29:16–22.
Article
CAS
PubMed
Google Scholar
Louie TJ, Cannon K, Byrne B, Emery J, Ward L, Eyben M, et al. Fidaxomicin preserves the intestinal microbiome during and after treatment of Clostridium difficile infection (CDI) and reduces both toxin reexpression and recurrence of CDI. Clin Infect Dis. 2012;55 suppl 2:S132–42.
Article
CAS
PubMed Central
PubMed
Google Scholar
Zhang F, Luo W, Shi Y, Fan Z, Ji G. Should we standardize the 1,700-year-Old fecal microbiota transplantation? Am J Gastroenterol. 2012;107(11):1755–5.
Article
PubMed
Google Scholar
Eiseman B, Silen W, Bascom GS, Kauvar AJ. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery. 1958;44(5):854–9.
CAS
PubMed
Google Scholar
van der Waaij D, Vossen JM, Altes CK, Hartgrink C. Reconventionalization following antibiotic decontamination in man and animals. Am J Clin Nutr. 1977;30(11):1887–95.
PubMed
Google Scholar
Heidt PJ, van der Waaij D, Vossen JM, Hendriks WD. The use of a human donor flora for recontamination following antibiotic decontamination. Prog Food Nutr Sci. 1983;7(3–4):53–63.
CAS
PubMed
Google Scholar
Youngster I, Sauk J, Pindar C, Wilson RG, Kaplan JL, Smith MB, et al. Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study. Clin Infect Dis. 2014;58(11):1515–22.
Article
PubMed Central
PubMed
Google Scholar
Vaishnavi C. Fecal microbiota transplantation for management of Clostridium difficile infection. Indian J Gastroenterol. 2014;33(4):301–7.
Article
PubMed
Google Scholar
Austin M, Mellow M, Tierney WM. Fecal microbiota transplantation in the treatment of Clostridium difficile infections. Am J Med. 2014;127(6):479–83.
Article
PubMed
Google Scholar
Brandt LJ, Aroniadis OC. An overview of fecal microbiota transplantation: techniques, indications, and outcomes. Gastrointestinal endoscopy. 2013;78(2):240–9.
Article
PubMed
Google Scholar
Bakken JS, Polgreen PM, Beekmann SE, Riedo FX, Streit JA. Treatment approaches including fecal microbiota transplantation for recurrent Clostridium difficile infection (RCDI) among infectious disease physicians. Anal Chem. 2013;24:20–4.
CAS
Google Scholar
Borody TJ, Brandt LJ, Paramsothy S, Agrawal G. Fecal microbiota transplantation: a new standard treatment option for Clostridium difficile infection. Expert Rev Anti Infect Ther. 2013;11(5):447–9.
Article
CAS
PubMed
Google Scholar
Brandt LJ, Aroniadis OC, Mellow M, Kanatzar A, Kelly C, Park T, et al. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol. 2012;107(7):1079–87.
Article
PubMed
Google Scholar
Burke KE, Lamont JT. Fecal transplantation for recurrent Clostridium difficile infection in older adults: a review. J Am Geriatr Soc. 2013;61(8):1394–8.
Article
PubMed
Google Scholar
de Vos WM. Fame and future of faecal transplantations – developing next-generation therapies with synthetic microbiomes. Microbial Biotechnology. 2013;6(4):316–25.
Article
PubMed Central
PubMed
Google Scholar
Di Bella S, Drapeau C, Garcia-Almodovar E, Petrosillo N. Fecal microbiota transplantation: the state of the art. Infect Dis Rep. 2013;5(2), e13.
Article
PubMed Central
PubMed
Google Scholar
Fuentes S, van Nood E, Tims S, Heikamp-de Jong I, ter Braak CJF, Keller JJ, et al. Reset of a critically disturbed microbial ecosystem: faecal transplant in recurrent Clostridium difficile infection. ISME J. 2014;8:1621–33.
Article
PubMed
Google Scholar
Gens KD, Elshaboury RH, Holt JS. Fecal microbiota transplantation and emerging treatments for Clostridium difficile infection. J Pharm Pract. 2013;26(5):498–505.
Article
PubMed
Google Scholar
Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis. 2011;53(10):994–1002.
Article
PubMed
Google Scholar
Högenauer C, Kump PK, Krause R. Tempered enthusiasm for fecal transplantation. Clin Infect Dis. 2014;59(9):1348–9.
Article
PubMed
Google Scholar
Jorup-Ronstrom C, Hakanson A, Sandell S, Edvinsson O, Midtvedt T, Persson AK, et al. Fecal transplant against relapsing Clostridium difficile-associated diarrhea in 32 patients. Scand J Gastroenterol. 2012;47(5):548–52.
Article
PubMed
Google Scholar
Kelly CP. Fecal microbiota transplantation — an old therapy comes of age. N Engl J Med. 2013;368(5):474–5.
Article
CAS
PubMed
Google Scholar
Khoruts A, Sadowsky MJ. Therapeutic transplantation of the distal gut microbiota. Mucosal Immunol. 2011;4(1):4–7.
Article
CAS
PubMed
Google Scholar
Moore T, Rodriguez A, Bakken JS. Fecal microbiota transplantation: a practical update for the infectious disease specialist. Clin Infect Dis. 2014;58(4):541–5.
Article
PubMed
Google Scholar
Pamer EG. Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns. Mucosal Immunol. 2014;7(2):210–4.
Article
CAS
PubMed
Google Scholar
Rao KMD, Young VBMDP, Aronoff DMMD. Commentary: fecal microbiota therapy: ready for prime time? Infect Control Hosp Epidemiol. 2014;35(1):28–30.
Article
PubMed Central
PubMed
Google Scholar
Ritter AS, Petri WAJ. New developments in chemotherapeutic options for Clostridium difficile colitis. Curr Opin Infect Dis. 2013;26(5):461–70.
CAS
PubMed
Google Scholar
Rubin TA, Gessert CE, Aas J, Bakken JS. Fecal microbiome transplantation for recurrent Clostridium difficile infection: report on a case series. Anal Chem. 2013;19:22–6.
Google Scholar
Russell GH, Kaplan JL, Youngster I, Baril-Dore M, Schindelar L, Hohmann E, et al. Fecal transplant for recurrent Clostridium difficile infection in children with and without inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2014;58(5):588–92.
Article
CAS
PubMed
Google Scholar
Senior K. Faecal transplantation for recurrent C difficile diarrhoea. Lancet Infect Dis. 2013;13(3):200–1.
Article
PubMed
Google Scholar
Tarr P. Fecal transplants for Clostridium difficile: Microbial Messiah or medical misadventure. In: Public Workshop: Fecal Microbiota for Transplantation: May 2013 2013; National Institutes of Health: Food & Drug Administration. 2013.
Google Scholar
Taur Y, Pamer EG. Harnessing microbiota to kill a pathogen: fixing the microbiota to treat Clostridium difficile infections. Nat Med. 2014;20(3):246–7.
Article
CAS
PubMed
Google Scholar
van Nood E, Speelman P, Nieuwdorp M, Keller J. Fecal microbiota transplantation: facts and controversies. Curr Opin Gastroenterol. 2014;30(1):34–9.
Article
PubMed
Google Scholar
van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368(5):407–15.
Article
PubMed
Google Scholar
Guidance for Industry: Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies. Food and Drug Administration; 2013, http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Vaccines/ucm361379.htm.
Ben-Amor K, Heilig H, Smidt H, Vaughan EE, Abee T, de Vos WM. Genetic diversity of viable, injured, and dead fecal bacteria assessed by fluorescence-activated cell sorting and 16S rRNA gene analysis. Appl Environ Microbiol. 2005;71(8):4679–89.
Article
CAS
PubMed Central
PubMed
Google Scholar
Bartsch SM, Umscheid CA, Fishman N, Lee BY. Is Fidaxomicin worth the cost? An economic analysis. Clin Infect Dis. 2013;57(4):555–61.
Article
PubMed Central
PubMed
Google Scholar
Juang P, Hardesty JS. Role of fidaxomicin for the treatment of Clostridium difficile infection. J Pharm Pract. 2013;26(5):491–7.
Article
PubMed
Google Scholar
Konijeti GG, Sauk J, Shrime MG, Gupta M, Ananthakrishnan AN. Cost-effectiveness of competing strategies for management of recurrent Clostridium difficile infection: a decision analysis. Clin Infect Dis. 2014;58(11):1507–14.
Article
PubMed Central
PubMed
Google Scholar
Khanna S, Pardi DS. Clostridium difficile infection: new insights into management. Mayo Clin Proc. 2012;87(11):1106–17.
Article
CAS
PubMed Central
PubMed
Google Scholar
Lowy I, Molrine DC, Leav BA, Blair BM, Baxter R, Gerding DN, et al. Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med. 2010;362(3):197–205.
Article
CAS
PubMed
Google Scholar
Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature. 2012;489(7415):220–30.
Article
CAS
PubMed Central
PubMed
Google Scholar
Liévin-Le Moal V, Servin AL. The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. Clin Microbiol Rev. 2006;19(2):315–37.
Article
PubMed Central
PubMed
Google Scholar
Clemente Jose C, Ursell Luke K, Parfrey Laura W, Knight R. The impact of the Gut microbiota on human health: an integrative view. Cell. 2012;148(6):1258–70.
Article
CAS
PubMed
Google Scholar
Vincent C, Stephens D, Loo V, Edens T, Behr M, Dewar K, et al. Reductions in intestinal clostridiales precede the development of nosocomial Clostridium difficile infection. Microbiology. 2013;1(1):18.
Google Scholar
Hookman P, Barkin JS. Clostridium difficile associated infection, diarrhea and colitis. World J Gastroenterol. 2009;15(13):1554–80.
Article
PubMed Central
PubMed
Google Scholar
Jernberg C, Lofmark S, Edlund C, Jansson JK. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J. 2007;1(1):56–66.
Article
CAS
PubMed
Google Scholar
Agito MD, Atreja A, Rizk MK. Fecal microbiota transplantation for recurrent C difficile infection: ready for prime time? Cleve Clin J Med. 2013;80(2):101–8.
Article
PubMed
Google Scholar
Weingarden AR, Chen C, Bobr A, Yao D, Lu Y, Nelson VM, et al. Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection. Am J Physiol Gastrointest Liver Physiol. 2013;306(4):G310–9.
Article
PubMed Central
PubMed
Google Scholar
You DM, Franzos MA, Holman RP. Successful treatment of fulminant Clostridium difficile infection with fecal bacteriotherapy. Ann Intern Med. 2008;148(8):632–3.
Article
PubMed
Google Scholar
Aas J, Gessert CE, Bakken JS. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis. 2003;36(5):580–5.
Article
PubMed
Google Scholar
Patel NC, Griesbach CL, DiBaise JK, Orenstein R. Fecal microbiota transplant for recurrent Clostridium difficile infection: mayo clinic in Arizona experience. Mayo Clin Proc. 2013;88(8):799–805.
Article
PubMed
Google Scholar
Rohlke F, Surawicz CM, Stollman N. Fecal flora reconstitution for recurrent Clostridium difficile infection: results and methodology. J Clin Gastroenterol. 2010;44(8):567–70. 510.1097/MCG.1090b1013e3181dadb1010.
Article
PubMed
Google Scholar
Persky SE, Brandt LJ. Treatment of recurrent Clostridium difficile-associated diarrhea by administration of donated stool directly through a colonoscope. Am J Gastroenterol. 2000;95(11):3283–5.
CAS
PubMed
Google Scholar
Lawley TD, Clare S, Walker AW, Stares MD, Connor TR, Raisen C, et al. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog. 2012;8(10), e1002995.
Article
CAS
PubMed Central
PubMed
Google Scholar
Buffie CG, Bucci V, Stein RR, McKenney PT, Ling L, Gobourne A, et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature. 2014;517:205–8.
Article
PubMed Central
PubMed
Google Scholar
Hamilton MJ, Weingarden AR, Sadowsky MJ, Khoruts A. Standardized frozen preparation for transplantation of fecal microbiota for recurrent clostridium difficile infection. Am J Gastroenterol. 2012;107(5):761–7.
Article
PubMed
Google Scholar
Youngster I, Russell GH, Pindar C, Ziv-Baran T, Sauk J, Hohmann EL. ORal, capsulized, frozen fecal microbiota transplantation for relapsing clostridium difficile infection. JAMA. 2014;312(17):1772–8.
Article
CAS
PubMed
Google Scholar
Bakken JS. Staggered and tapered antibiotic withdrawal with administration of kefir for recurrent clostridium difficile infection. Clin Infect Dis. 2014;59(6):858–61.
Article
PubMed
Google Scholar
Allen SJ, Wareham K, Wang D, Bradley C, Hutchings H, Harris W, et al. Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2013;382(9900):1249–57.
Article
PubMed
Google Scholar
Kim K-H, Fekety R, Batts DH, Brown D, Cudmore M, Silva J, et al. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis. 1981;143(1):42–50.
Article
CAS
PubMed
Google Scholar
Lawley TD, Clare S, Walker AW, Goulding D, Stabler RA, Croucher N, et al. Antibiotic treatment of Clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts. Infect Immun. 2009;77(9):3661–9.
Article
CAS
PubMed Central
PubMed
Google Scholar
Cohen Stuart HMD, Gerding Dale NMD, Stuart Johnson MD, Kelly Ciaran PMD, Loo Vivian GMD, McDonald LCMD, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Cont Hosp Ep. 2010;31(5):431–55.
Article
CAS
Google Scholar